Journals / Turkish Journal of Cancer / 2003 / Cilt: 33 - Sayı: 3

p53, Fas (APO 1) and Ki-67 immunostaining in testicular germ-cell tumors and correlation with pathologic stage, tumor size, necrosis, and vascular invasion

Pages
137–143
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was concluded that Ki-67 and Fas expressions may be important prognostic parameters in the staging of germ-cell tumors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The objective of this study was to analyze the relationships among immunohistochemical expression of p53, Ki-67, Fas antigens (CD 95) and tumor size, pathological stage, and the presence of vascular invasion and necrosis in testicular germ-cell tumors.
📊
Key Findings & Data:Representative archival tissues from 36 testicular germ cell tumors were studied for p53, Ki-67 and Fas antigens by immunohistochemistry.
💡
Conclusion & Impact:It was concluded that Ki-67 and Fas expressions may be important prognostic parameters in the staging of germ-cell tumors.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Neoplazmlar · germ hücreli ve embriyonel · İmmünohistokimya

Abstract

The objective of this study was to analyze the relationships among immunohistochemical expression of p53, Ki-67, Fas antigens (CD 95) and tumor size, pathological stage, and the presence of vascular invasion and necrosis in testicular germ-cell tumors. Representative archival tissues from 36 testicular germ cell tumors were studied for p53, Ki-67 and Fas antigens by immunohistochemistry. All of the tumors' size, pathological stage, and the presence of vascular invasion and necrosis within tumors were recorded. Signif-icant correlation with pathological phase was found for Ki-67 and Fas expressions. No correlation was determined between any antibody and maximum tumor diameter or necrosis. While a positive correlation (p<0.05) with vascular invasion in mixed germ-cell tumors was found with Ki-67 staining intensity, no significant correlation (p>0.05) was found with Fas and p53. In the previous and current studies, the percentage of embryonal carcinoma and the presence or absence of vascular invasion in NSGCT appear to be reliable prognostic factors to identify patients at high risk and low risk for occult retroperitoneal disease. Additionally, our results, suggest that Ki-67 plays a role at all stages of tumorogenesis and that it could be used as an auxiliary to other parameters in tumor prognosis. It was concluded that Ki-67 and Fas expressions may be important prognostic parameters in the staging of germ-cell tumors.

🔖

Cite This Article

KAYASELÇUK, F., POLAT, A., KILINÇ, F., GÜVEL, S., TUNCER, İ. (2003). p53, Fas (APO 1) and Ki-67 immunostaining in testicular germ-cell tumors and correlation with pathologic stage, tumor size, necrosis, and vascular invasion. Turkish Journal of Cancer, Cilt: 33 - Sayı: 3, 137–143. https://ajindex.com/articles/368354

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ulbright TM, Roth LM. Testicular and paratesticular tumors. In: Sternberg SS, editor. Diagnostic surgical pathology. 3rd ed. Philadelphia: Lippincott Williams& Wilkins, 1999; 1973- 2034
  2. Bartkova J, Bartek J, Lukas J, et al. p53 protein alternations in human testicular cancer including pre-invasive intratubuler germ cell neoplasia. Int J Cancer 1991;49:196-202
  3. Fleischhacker M, Strohmeyer T, Imai Y, et al. Mutations of the p53 gene are not detectable in human testicular tumors. Mod Pathol 1994;7:435-39
  4. Lewis DJ, Sesterhenn IA, McCarthy WF, et al. Immunohistochemical expression of p53 tumor suppressor gene protein in adult germ cell testis tumors: Clinical correlation in stage I disease. J Urol 1994;152:418-23
  5. Kuczyk MA, Serth J, Bokemeyer C, et al. Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis. Cancer 1996;78:1958-66
  6. Kuczyk MA, Serth J, Bokemeyer C, et al. Overexpression of the p53 oncoprotein in carcinoma in situ of the testis. Pathol Res Pract 1994;190:993-98
  7. Serth J, Kuczyk MA, Derendorf L, et al. Identification of frequent p53 gene alterations in testicular cancer by in situ molecular genetic and immunohistochemical analysis. J Urol 1994;151(Pt 2):408A
  8. Eid H, Van der Looij M, Institoris E, et al. Is p53 expression, detected by immunohistochemistry, an important parameter of response to treatment in testis cancer? Anticancer Res 1997;17:2263-9
  9. Eid H, Mingfang L, Institoris E, et al. MRP expression of testicular cancers and its clinical relevance. Anticancer Res 2000;20:4019-22
  10. Moul JW, Heidenreich A. Prognostic factors in low-stage nonseminomatous testicular cancer. Oncology 1996;10:1359- 74
  11. Rieger E, Hofmann-Wellenhof R, Soyer HP, et al. Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. J Cutan Pathol 1993;20:229-36
  12. Yamanaka N, Harabuchi Y, Kataura A. The prognostic value of Ki-67 antigen in Non-Hodgkin lymphoma of Waldeyer ring and the nasal cavity. Cancer 1992;70:9: 2342-9
  13. Dervan PA, Magee HM, Buckley C, et al. Proliferating Cell Nuclear Antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue. Am J Clin Pathol 1992;97:5:21-8
  14. Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferationassociated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J